HilleVax, Inc. (HLVX)
NASDAQ: HLVX · IEX Real-Time Price · USD
16.63
+1.01 (6.47%)
At close: Mar 28, 2024, 4:00 PM
16.30
-0.33 (-1.98%)
After-hours: Mar 28, 2024, 4:05 PM EDT

HilleVax Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Selling, General & Admin
26.6616.715.761.3
Research & Development
106.6845.9110.010
Other Operating Expenses
02.537.660
Operating Expenses
133.3565.1153.431.3
Operating Income
-133.35-65.11-53.43-1.3
Interest Expense / Income
2.393.412.840.03
Other Expense / Income
-12.1791.2846.140.78
Pretax Income
-123.57-159.81-102.41-2.1
Net Income
-123.57-159.81-102.41-2.1
Shares Outstanding (Basic)
412764
Shares Outstanding (Diluted)
412764
Shares Change
49.55%383.12%28.65%-
EPS (Basic)
-3.04-5.89-18.22-0.48
EPS (Diluted)
-3.04-5.89-18.22-0.48
Free Cash Flow
-97.53-66-7.34-1.27
Free Cash Flow Per Share
-2.40-2.43-1.31-0.29
EBITDA
-119.02-155.25-99.56-2.07
Depreciation & Amortization
2.161.1500
EBIT
-121.17-156.4-99.56-2.07
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).